AML, Adult research hub

OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

This study looks at how well a medicine called ivosidenib (IVO) works for adults in France with a specific type of acute myeloid leukaemia (AML). It focuses on patients whose AML has a particular gene change (IDH1 mutation) and who received IVO through a special access programme.